Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Carbonic anhydrase IX (CAIX) is a membrane-associated carbonic anhydrase (CA), strongly induced by hypoxia. CAIX is overexpressed in a variety of tumor types and associated with increased metastasis and poor prognosis. An inhibitor of CAs, acetazolamide has been reported to inhibit invasion. We used RNA interference (RNAi) to examine the function of CAIX in MDA468 and MDA231 breast carcinoma cells, which express high levels of CAIX under hypoxia. Hypoxia-induced CA activity was completely blocked by specific RNAi (P < 0.01). RNAi-treated cells showed growth delay in dense monolayer culture and a 50% reduction in clonogenic survival under hypoxia. In the MDA468 cells, there was no effect of RNAi treatment on invasion. In a cell line that did not induce CAIX under hypoxia, RT112, we found no effect on the ability of cells transfected with CAIX to invade or migrate. Thus, CAIX plays an important role in the growth and survival of tumor cells under normoxia and hypoxia, making it a potential target for cancer therapy, but is not involved in invasion.

Original publication

DOI

10.1158/0008-5472.CAN-03-2224

Type

Journal article

Journal

Cancer Res

Publication Date

01/09/2004

Volume

64

Pages

6160 - 6165

Keywords

Acetazolamide, Adenocarcinoma, Antigens, Neoplasm, Breast Neoplasms, Carbonic Anhydrase IX, Carbonic Anhydrase Inhibitors, Carbonic Anhydrases, Cell Division, Cell Hypoxia, Cell Line, Tumor, Cell Movement, Cell Survival, Colonic Neoplasms, Humans, Neoplasm Invasiveness, RNA Interference, Transfection, Up-Regulation